Shares of Aurora Cannabis (NYSE:ACB,TSX:ACB) jumped on Wednesday (September 4) after it announced the sale of C$86.5 million worth of its remaining shares of The Green Organic Dutchman (TGOD) (TSX:TGOD,OTCQX:TGODF). 

The Alberta-based cannabis giant opened at C$7.71 on Wednesday, jumping almost 2 percent from its previous close of C$7.57 on Tuesday (September 3).


The announcement came after market close on Tuesday. According to reports, the cannabis firm has relieved itself of over 28 million TGOD shares for C$3 each, representing a 10.5 percent stake.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

TGOD’s closing price was C$3.51 on Tuesday, resulting in a discount of 14.5 percent for Aurora. Its shares dropped sharply to C$3 at opening on Wednesday, matching Aurora’s sale price, before dropping further to C$2.96 by 10:20 a.m. EDT.

Aurora said that, while it no longer holds any shares of TGOD, it will retain the warrants to purchase over 16 million shares of the Ontario-based grower. Aurora also said the sale has raked in a 50 percent internal rate of return for the company.

Aurora CEO Terry Booth said in a press release that Aurora regularly adjusts its alignment strategy to maximize yields from its investments.

“When we acquired Whistler Medical Marijuana Corporation — an iconic and premium organic cannabis producer — our interest in TGOD became less important to our core strategy,” said Booth.

Aurora’s all-share acquisition of Whistler brought the BC-based cannabis brand into Aurora’s portfolio back in March of this year.

The sale ends a long relationship between the two firms tracing back to January 2018, when Aurora first announced a strategic investment in TGOD as well as a supply contract.

Initially, Aurora acquired over 33 million units at C$1.65 each for a total value of C$55 million. The deal also gave Aurora the right to buy up to 20 percent of TGOD’s annual cannabis yield from two of its production facilities.

Aurora furthered its stake in May last year when it invested C$23.1 million as a part of TGOD’s initial public offering, purchasing 6.3 million units for a total of 39.7 million common shares.

TGOD responded to the sale on Wednesday before markets opened, saying it will improve company’s revenue and gross margin mix as it frees up the organic cannabis previously being sold to Aurora as a part of the original supply agreement.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“This is the right next step in the relationship as both companies mature and our respective strategies evolve,” said TGOD CEO Brian Athaide in a statement.

TGOD added that Aurora played a crucial part in its early development, including the initial building of its production facilities.

The sale follows an announcement on Tuesday from TGOD stating the company has received approval from Health Canada to start operations at its facility in Hamilton, Ontario. It also follows the company’s first shipment of cannabis to the Ontario Cannabis Store in August, marking TGOD’s introduction into Canada’s recreational marijuana market.

TGOD reported revenues of C$2.9 million but losses of C$16.6 million for the second quarter this year. The company attributed the loss to the cost of setting itself up to commercialize its products in Canada and abroad.

One of the company’s international moves is a deal between Mediakos and TGOD’s subsidiary, HemPoland, to distribute its cannabidiol brand to pharmacies in Germany.

Some of TGOD’s biggest shareholders apart from Aurora are ETF Managers Group and Horizons ETFs Management, both of which have cannabis exchange-traded funds with holdings in TGOD.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

CANBUD Distribution Corp. (CSE:CBDX, FSE:CD0) leverages on timely and methodical execution of its revenue generating plan. It operates a trinitarian enterprise model in the plant-based protein, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) spaces. (www.canbudcorp.com).

Keep reading... Show less

(TheNewswire)

Keep reading... Show less

Market entry will address pent-up demand in the Japanese & Philippine markets for TRACE proprietary plant-based mineral formulation and wellness-focused products

Emerging leader in innovative health and wellness beverages and natural products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that has entered into an exclusive sales agency distribution agreement with Yokohama-based Mirai Marketing Inc. (“Mirai”) to bring Naturo Group’s TRACE proprietary plant-based mineral consumer products to Mirai’s extensive Japanese and Philippine sales and distribution networks.

Keep reading... Show less

Further to its press release dated April 12, 2021, Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or “ Ayurcann ”), is pleased to announce that it has oversubscribed and upsized its non-brokered private placement (the “Offering”) due to strong investor demand. The Company now anticipates that the Offering will be completed for gross proceeds of not less than $550,000.00, consisting of not less than 2,910,053 units (“Units”) at a price of $0.189 per Unit. Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one Common Share purchase warrant (a “Warrant”). Each Warrant is exercisable to acquire one Common Share at an exercise price of C$0.38 per Common Share for a period of 36 months from the date of closing of the Offering (the “Closing Date”), scheduled for April 22, 2021. The Units will have a hold period of four months and one day from the date of issuance.

Ayurcann CEO Igal Sudman commented: “We are very pleased with the demand we are seeing for the Offering. The feedback we have received to date is showing that our business is resonating with investors. We’re looking forward to closing the offering and proceeding with the planned Phase 2 build out, which will help greatly increase our facility’s capacity.”

Keep reading... Show less

UK InstaCoin APP Promises to Open NFTs up to the Masses through Social Media

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to provide an update on its recent investment in InstaCoin Technologies Ltd., a newly formed UK entity

Keep reading... Show less